MarketCap
Facebook
X
TelegramAnnual report 2024
added 04-18-2026
ICON Public Limited Company ROCE Ratio 2011-2026 | ICLR
Annual ROCE Ratio ICON Public Limited Company
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 4.69 | 16.94 | 24.4 | 21.41 | 21.41 | 23.41 | 24.58 | 20.43 | 12.88 | 8.62 | 4.04 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 24.58 | 4.04 | 16.62 |
Quarterly ROCE Ratio ICON Public Limited Company
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.22 | 4.29 | 2.24 | 7.8 | 11.63 | 17.96 | 24.23 | 22.28 | 16.96 | 24.29 | 25.28 | 28.76 | 21.59 | 28.92 | 28.94 | 28.46 | 21.56 | 29.1 | 29.29 | 30.25 | 24.18 | 31.95 | 32.19 | 32.74 | 24.91 | 33.18 | 33.67 | 32.21 | 21.61 | 27.48 | 25.09 | 23.26 | 15.19 | 19.07 | 17.07 | 15.52 | 10.16 | 13.06 | 12.08 | 10.41 | 6.19 | 5.66 | 2.23 | 2.79 | 3.23 | -0.53 | 2.18 | 1.58 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 33.67 | -0.53 | 18.47 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.31 | -19.63 % | $ 1.74 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 112.11 | -1.0 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
-9.09 | $ 19.11 | 1.19 % | $ 554 M | USA |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 15.85 | -2.1 % | $ 479 M | USA |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 142.72 | -0.36 % | $ 22.7 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-69.04 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 93.78 | -2.99 % | $ 6.33 B | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 418.32 | -0.2 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 038.75 | -0.3 % | $ 21.4 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 3.62 | - | $ 335 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.29 | -0.9 % | $ 1.06 B | USA |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 152.19 | -4.36 % | $ 7.54 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 18.61 | -1.69 % | $ 417 M | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-76.66 | $ 188.15 | -4.45 % | $ 18.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.33 | $ 25.27 | -0.96 % | $ 24 B |  Niderland |
 |
Guardant Health
GH
|
440.3 | $ 94.27 | -4.45 % | $ 11.8 B | USA |
 |
Personalis
PSNL
|
-33.71 | $ 6.38 | -4.92 % | $ 569 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 5.72 | -1.72 % | $ 239 M | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 53.0 | 0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-125.14 | $ 2.25 | -6.67 % | $ 5.17 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 252.68 | -0.53 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 438.85 | -2.07 % | $ 165 B | USA |
 |
Trinity Biotech plc
TRIB
|
-29.73 | $ 0.56 | -3.63 % | $ 201 M |  Irlanda |
 |
Celcuity
CELC
|
-171.24 | $ 135.17 | 0.33 % | $ 6.32 B | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-28.81 | $ 48.65 | -8.12 % | $ 2.91 B | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 8.21 | -2.61 % | $ 1.78 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 187.55 | -0.21 % | $ 20.8 B | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |